Prostanorm

General characteristics. Structure:

Active component: Простанорм® extract dry (received from mix of medicinal vegetable raw materials: a St. John's Wort of a grass, a golden rod Canadian herbs, glycyrrhizas of roots, a purple cone-flower purple rhizomes with roots (1:1:1:1), with the maintenance of the sum of flavonoids in terms of Rutinum of 5%) – 200 mg. 

Excipients: potato starch – 90,42 mg, lactose – 103,16 mg, sucrose – 1,82 mg, gelatin – 0,96 mg, talc – 1,82 mg, stearic acid – 1,82 mg. 

The cover received by a building method: sucrose – 224,98 mg, talc – 3,04 mg, silicon dioxide colloid – 3,70 mg, titanium dioxide – 4,75 mg, povidone low-molecular – 3,56 mg, magnesium a hydroxycarbonate – 44,26 mg, dye 0 Tropeolin – 0,02 mg, dye Azorubin – 0,06 mg. 

Mastic for glossing: beeswax – 0,27 mg, talc – 0,09 mg, sunflower oil – 0,27 mg.

Pharmacological properties:

Drug has the expressed prostatotropny effect at the expense of antiinflammatory, analgeziruyushchy, bacteriostatic (staphylococcus, enterococci) effect. Простанорм® improves microcirculation of tissues of prostate gland, ejaculate indicators (including mobility of spermatozoa) at a patozoospermiya and a prostate secret because of chronic prostatitis; normalizes an urination.

Indications to use:

Chronic prostatitis, infertility (patozoospermiya) owing to chronic prostatitis (in complex therapy), the antiinflammatory and normalizing an urination means.

Route of administration and doses:

Inside on 1-2 tablets 3 times a day in 30 minutes prior to food or in 40 minutes after food. Duration of a course of treatment is up to 6-7 weeks. Carrying out a repeated course of treatment perhaps after consultation with the doctor.

Side effects:

Allergic reactions are possible.

Interaction with other medicines:

Incompatibility with medicines of other groups is not revealed. Treatment can be combined using biogenic stimulators, vitamins, antibacterial drugs, massage of a prostate and physiotherapeutic procedures.

Contraindications:

Hypersensitivity to drug components, an acute glomerulonephritis.

With care: at diseases for which treatment use of immunoexcitants is not recommended (drug contains purple cone-flower extract).

Overdose:

Cases are not described.

Storage conditions:

In the place protected from light at a temperature not above 20 °C. 

To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

Tablets on 0,2 g, coated. 

On 10 tablets in a blister strip packaging from a film of the polyvinyl chloride and printing aluminum foil varnished or papers packaging with a polyethylene covering. 

On 30, 50 tablets in banks of light-protective glass. On 30, 50 tablets in banks polymeric for storage of medicines and vitamins or in banks polymeric with control of the first opening and the shock-absorber. 

Each can, 1, 2 or 3 blister strip packagings together with the application instruction are placed in a pack from a cardboard.